Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05674318

The Effect of Alpha-lactalbumin on Microbiota Composition

Conditions: Alpha-lactalbumin, Microbiota, Dysbiosis

Sex: All

Ages: 25 Years – 50 Years

Phase: NA

Enrollment: 20

Sponsor: Lo.Li.Pharma s.r.l

Location: Italy

Summary

To evaluate the effects on microbiota composition after the administration of an oral supplementation based on Alpha-lactalbumin in subjects with dysbiosis.

Eligibility Criteria

Inclusion Criteria:condition of dysbiosisExclusion Criteria:antibiotic treatment within 1 monthprobiotic or prebiotic treatmentsconcomitant inflammatory intestinal diseasespregnancyneoplastic diseasesallergy to milk protein (Alpha-lactalbumin)substance abuse

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05674318). StuddyBuddy aggregates publicly available trial information.